KKR posted fourth-quarter net income growth as lower expenses offset a drop in revenue, and assets under management at the buyout firm grew as it prepared for a potential deal bonanza in the second ...

As the global private equity industry took tentative steps toward recovery in 2024, Japan raced ahead. Read more here.

In a report released on January 29, Michael Cherny from Leerink Partners reiterated a Hold rating on Henry Schein (HSIC – Research Report), ...

Securities updated their financial outlook on Henry Schein (NASDAQ:HSIC), increasing the price target to $78 from the previous $75, while maintaining a Neutral rating on the company's stock. According ...

Mizuho Securities analyst Steven Valiquette has maintained their neutral stance on HSIC stock, giving a Hold rating on January 23.Invest with ...

Health-care companies fell amid mixed earnings. Shares of Danaher, which makes tools and equipment for the biotech, life-sciences and diagnostics businesses, plunged by roughly 10% after it posted ...

Private equity firm KKR & Co. Inc. has invested $250 million in Henry Schein Inc., Long Island’s largest publicly traded ...

Henry Schein Inc., a leading healthcare solutions provider, has secured a $250 million investment from private equity ...

Henry Schein receives $250 million strategic investment from KKR, making them largest non-index fund shareholder.

Henry Schein, Inc. (NASDAQ:HSIC) shares are trading higher on Wednesday. The medical and dental supplies distributor ...

The Public Employee Retirement System of Idaho continues to boost its private equity program with $370 million in investments ...

KKR is set to become the largest non-index fund shareholder in Henry Schein, acquiring a 12% stake through a $250 million ...